Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05698199
What this trial is testing

Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)

Who this might be right for
Glioblastoma
Immunomic Therapeutics, Inc. 10
Not applicableStudy completedNCT03557372
What this trial is testing

Mathematical Model-Adapted Radiation In Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Dana-Farber Cancer Institute 14
Testing effectiveness (Phase 2)WithdrawnNCT00021307
What this trial is testing

Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Fox Chase Cancer Center
Not applicableStudy completedNCT05229198
What this trial is testing

ALBATROSS Study: International Multicenter Study for Prospective Validation of Imaging Biomarkers Calculated at Vascular Habitats of High-grade Gliomas

Who this might be right for
Astrocytoma, Grade IV
Juan M Garcia-Gomez 300
Testing effectiveness (Phase 2)Study completedNCT01026493
What this trial is testing

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 257
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT00392171
What this trial is testing

The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)

Who this might be right for
GliomaAstrocytomaOligodendroglioma+1 more
Merck Sharp & Dohme LLC 120
Not applicableStudy completedNCT06600399
What this trial is testing

Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma

Who this might be right for
Glioblastoma
Lanzhou University Second Hospital 26
Testing effectiveness (Phase 2)Study completedNCT00540722
What this trial is testing

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 56
Not applicableWithdrawnNCT05927610
What this trial is testing

Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma

Who this might be right for
Glioblastoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00006386
What this trial is testing

Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 80
Early research (Phase 1)Ended earlyNCT04963413
What this trial is testing

RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.

Who this might be right for
Glioblastoma
University of Florida 6
Testing effectiveness (Phase 2)UnknownNCT04583020
What this trial is testing

Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Peking Union Medical College Hospital 42
Large-scale testing (Phase 3)UnknownNCT00003788
What this trial is testing

Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Colorado Health Foundation 270
Early research (Phase 1)Study completedNCT00006474
What this trial is testing

Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Early research (Phase 1)Study completedNCT00005813
What this trial is testing

Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Dartmouth-Hitchcock Medical Center
Testing effectiveness (Phase 2)UnknownNCT05163080
What this trial is testing

SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)

Who this might be right for
Newly Diagnosed Glioblastoma
MimiVax, LLC 247
Testing effectiveness (Phase 2)Study completedNCT00961090
What this trial is testing

Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery

Who this might be right for
Glioblastoma
Matthew R Quigley 72
Testing effectiveness (Phase 2)Study completedNCT01280552
What this trial is testing

ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Precision Life Sciences Group 124
Not applicableLooking for participantsNCT05231655
What this trial is testing

Ex VIvo DEtermiNed Cancer Therapy

Who this might be right for
Bladder CancerKidney CancerMelanoma+3 more
Sheffield Teaching Hospitals NHS Foundation Trust 600
Next Page